HOME >> BIOLOGY >> NEWS
Peripheral 'Swatch' watches are a powerful force in bodys circadian rhythms

BOSTON, MA The daily rhythms of the bodyonce thought to be strictly governed by a master clock lodged in the brainappear to be driven to a remarkable degree by tiny timepieces pocketed in organs all over the body. Whats more, these peripheral timepieces appear to be strikingly idiosyncratic in appearancemore like Swatch watches than classic Timexes. Clocks located in the liver and heart appear to use very different sets of genes to perform essentially the same functions, researchers at Harvard Medical School and the Harvard School of Public Health report in the April 21 Nature online.

The study, among the first to explore circadian time mechanisms outside the brain, could have a potentially broad impact on the burgeoning fields of circadian medicine and postgenomic science.

Clinicians have known for years that organs function at different ratesthe heart beats, kidneys transport ions and electrolytes, the liver metabolizes lipids, sugars, and amino acids differently over the course of the dayand have used this knowledge to design more effective drug regimens for patients. A better understanding of what drives those local rhythms, and how they go wrong, could aid physicians efforts.

The discovery that different genes perform similar circadian functions also bears on attempts to move beyond the Human Genome Project, to find functions for the tens of thousands of newly described genes. "There is a lesson here beyond clocks, and that is that the relationship between gene regulation and physiology has a giant black box," said the studys principal investigator, Charles Weitz, Assistant Professor of Neurobiology at Harvard Medical School.

The existence of peripheral timepieces had been suspected but no one knew how much control they actually had or why they were in organs such as the heart, lungs, and liver in the first place. Using newly developed gene chips, Charles Weitz, Kai-Florian Storch, Research Fellow in Neurobiology at Harvard Me
'"/>

Contact: Donna Burtanger
donna_burtanger@hms.harvard.edu
617-432-0442
Harvard Medical School
21-Apr-2002


Page: 1 2

Related biology news :

1. Scientists Show For The First Time How Leprosy Bug Targets Peripheral Nerves
2. Sex-Specific Behavior Controlled By Peripheral Nervous System
3. Discovery Channel special watches OSU chimps learn to read
4. FDA approves VYTORIN, first and only to powerfully reduce LDL cholesterol through dual inhibition
5. Spanish scientists develop powerful tool for exploration and integration of biological information
6. Volcanic soils yield new clues about the emergence of powerful chiefdoms in Hawaii
7. Fruits offer powerful protection from skin cancer
8. Grant of powerful computer to Rutgers-Newark will increase understanding of brain activity
9. Hopkins is first US institution to obtain powerful genotyping system
10. Atomic force microscope powerful new tool for measurement of particle attraction
11. Brain banks are a powerful tool for alcohol research

Post Your Comments:
(Date:6/18/2013)... Arlington environmental engineer has been awarded a $394,300 ... ensure water quality and flow in the new ... Andrew Kruzic, UT Arlington associate professor of civil ... to add monochloramine to the water in an ... pump stations and pipelines. Adding monochloramine is widely ...
(Date:6/18/2013)... The National Institutes of Health has awarded $12.7 ... a selection of pharmaceutical industry compounds to explore ... including Alzheimer,s disease, Duchenne muscular dystrophy and schizophrenia. ... Uses for Existing Molecules, is led by the ... funded by the NIH Common Fund. , The ...
(Date:6/18/2013)... 10% of breast and ovarian cancers are familial in ... attributable to inherited mutations from the parents in genes ... mutations, PARP inhibitors, which are currently in clinical trials, ... option for personalised cancer treatment, an alternative to standard ... of these patients generate resistance to the drug and, ...
Breaking Biology News(10 mins):UT Arlington research to benefit quality, flow in 150-mile Integrated Pipeline 2NIH to fund collaborations with industry to identify new uses for existing compounds 2NIH to fund collaborations with industry to identify new uses for existing compounds 3NIH to fund collaborations with industry to identify new uses for existing compounds 4An article in 'Cell' reveals a new resistance mechanism to chemotherapy in breast and ovarian cancer 2
(Date:6/19/2013)... (PRWEB) June 19, 2013 India’s ... business can potentially be worth up to a ... opportunity, the Indian government is taking serious action ... the process. , This presentation will examine:, ... regulations ,     Immediate and long term impacts ...
(Date:6/19/2013)... Applied Rigaku Technologies, Inc. is pleased to publish ... sulfur in ultra-low sulfur diesel (ULSD) using the new ... . The analysis detailed in Rigaku Application Note 1272 ... International Standard specifies an energy dispersive X-ray fluorescence (EDXRF) ... automotive gasoline. , Regulations around the world have limited ...
(Date:6/19/2013)... A new look at “big glass” and visionary ... highlight technical sessions at SPIE Photomask Technology 2013 ... year, the three-day event is the industry’s largest mask ... 100 technical presentations and numerous networking lunches and receptions. ... and photonics , the meeting will be held at ...
(Date:6/19/2013)... Express Diagnostics Int’l, Inc., manufacturer of ... it has received Class III medical device license approval ... DrugCheck® NxStep Onsite Drug Screen Cup in Canada. ... device in near-patient settings, such as physicians’ offices. , ... Canada Class III approval for 24 different drugs and ...
Breaking Biology Technology:Rigaku Publishes New Application Note for Analysis of ULSD Per ISO 13032 2‘Big Glass’ and Visions for the Future are on the Program for SPIE Photomask Technology 2‘Big Glass’ and Visions for the Future are on the Program for SPIE Photomask Technology 3Express Diagnostics’ DrugCheck® On-site Test Cup Receives Health Canada Class III Medical Device Approval 2Express Diagnostics’ DrugCheck® On-site Test Cup Receives Health Canada Class III Medical Device Approval 3
Cached News: